The list of critical medicinal products, published by the European Commission together with the European Medicines Agency and the heads of member states' drug agencies, contains 200 active substances used in medicines considered critical to health systems across the European Union, for which continuity of supply must be guaranteed to avoid shortages.
Inclusion on the list means that preventing shortages of these drugs is particularly important, as they can cause significant harm to patients and pose serious challenges to health care systems. A drug...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].